Last deal

Amount

Non-equity Assistance

Stage

16.09.2019

Date

2

all rounds

$5.47M

Total amount

date founded

Financing round

General

About Company
Algiax is a biotechnology company developing innovative products for nervous system diseases, particularly neuropathic pain.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2011

Number of employees

Company Type

For Profit

Last funding type

Non-equity Assistance

IPO status

Private

Description

Founded in 2011, Algiax Pharmaceuticals is financially stable after raising 4.3 million Euros in Series A financing. Their pipeline includes AP-325, a small-molecule GABAA receptor modulator currently in clinical trials for neuropathic pain, as well as other candidates for cognitive impairment and other central nervous system indications. Based in Erkrath, Germany, Algiax is dedicated to addressing the high unmet medical need in the field of nervous system diseases.
Contacts
Similar Companies
1000
Dantari

Dantari

Dantari is a biotechnology company that develops breakthrough medicines for cancer and other serious diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Thousand Oaks, CA, USA

total rounds

2

total raised

$47M
Spexis

Spexis

Spexis is a Swiss biopharmaceutical company that develops transformative biotechnological medicines.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

4123 Allschwil, Switzerland
Newron Pharmaceuticals

Newron Pharmaceuticals

Newron Pharmaceuticals is developing novel therapies for diseases of the central nervous system and pain.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

20091 Bresso, Metropolitan City of Milan, Italy

total rounds

10

total raised

$129.43M
Omeros

Omeros

Omeros develops therapeutics for inflammation, coagulopathies, and CNS disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Seattle, WA, USA

total rounds

21

total raised

$927.05M

Financials

Funding Rounds
2
2

Number of Funding Rounds

$5.47M

Money Raised

Their latest funding was raised on 16.09.2019. Their latest investor VentureOut. Their latest round Non-equity Assistance

Date 
Funding Round 
Investors 
Money Raised 
Lead 
16.09.2019
1
16.05.2012
2
$5.47M
Local Amount - EUR 4.3M
KfW

KfW

KfW is a German state-owned development bank that promotes sustainable economic, social, and ecological development worldwide.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Financial Services, Finance, Venture Capital

Location

Frankfurt, Germany

total rounds

1

total raised

$55.4M

count Of Investments

165

count Of Exists

37
High-Tech Grunderfonds

High-Tech Grunderfonds

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven start-ups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Bonn, Germany

count Of Investments

838

count Of Exists

107
Co-Investors
Investors
3
2

Number of lead investors

3

Number of investors

Investor 
Lead 
Round 
Partners 
No
Non-equity Assistance
Yes
Series A
VentureOut

VentureOut

VentureOut empowers startups to launch, raise capital, and scale in New York City.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Location

New York, NY, USA

count Of Investments

1071

count Of Exists

79
KfW

KfW

KfW is a German state-owned development bank that promotes sustainable economic, social, and ecological development worldwide.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Financial Services, Finance, Venture Capital

Location

Frankfurt, Germany

total rounds

1

total raised

$55.4M

count Of Investments

165

count Of Exists

37
High-Tech Grunderfonds

High-Tech Grunderfonds

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven start-ups.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Bonn, Germany

count Of Investments

838

count Of Exists

107

People

Founders
2

Birgit Hasse

Birgit Hasse is a neuroscientist with a degree in biology and PhD from Düsseldorf University. She has more than 9 years experience in pre-clinical development in pharmaceutical R&D. Birgit has specialised in the exploratory phase of preclinical development within the field of neurosciences with a primary focus on neuropathic pain. Birgit is co-founder of Algiax and was actively involved in the fundraising for the Series A financing. Birgit has patented more than 4 development candidates in neuropathic pain and trauma-related disorders of the nervous system.

current job

Algiax Pharmaceuticals
Algiax Pharmaceuticals

organization founded

1

Birgit Hasse

Guido Koopmans
Guido Koopmans

Guido Koopmans

current job

Algiax Pharmaceuticals
Algiax Pharmaceuticals

organization founded

1

Guido Koopmans

Employee Profiles
6
Guido Koopmans

Guido Koopmans

Chief Scientific Officer

Ingo Lehrke

Ingo Lehrke

Chief Executive Officer

Jürgen Schumacher

Jürgen Schumacher

CEO

Birgit Hasse

Co Founder & Associate Head of Research & Development

Stefan Fischer

CFO

Activity

Recent News
0